David Chadwick, Richard Gray. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Azathioprine/economicsAzathioprine/therapeutic useCost-Benefit AnalysisHumansImmunosuppressive Agents/economicsImmunosuppressive Agents/therapeutic useMultiple Sclerosis/drug therapyRisk Sharing, Financial
Substances: See more » Immunosuppressive AgentsAzathioprine
Year: 2003 PMID: 12775632 PMCID: PMC1126067 DOI: 10.1136/bmj.326.7400.1212-a
Source DB: PubMed Journal: BMJ ISSN: 0959-8138